Estradiol Patch
Product Images NDC 68382-326

This text appears to be a data table showing changes in a treatment over time. The baseline values are given at 4 and -6, followed by values at 6 months, 12 months, 18 months, and 24 months. The treatment is compared to a placebo, with different dosage levels indicated by 0.025 mg per day, 0.05 mg per day, and 0.06 mg per day. The last line mentions a dosage of 0.1 mg per day.*

Estradiol Patch is a medication used for hormone replacement therapy. It contains estradiol, which is a form of estrogen. The patch is designed to deliver a controlled dose of estradiol through the skin. It has a protective film and backing for proper application. Figure C and Figure D might refer to visual instructions or illustrations related to the patch.*

This text appears to be a description of a transdermal system containing estradiol. The system is applied once weekly and contains 3.777 mg of estradiol USP, providing 0.05 mg of estradiol per day. The inactive components of the system include acrylic adhesive, colloidal silicon dioxide, ethyl oleate, glyceryl monolaurate, isopropyl myristate, povidone, and polyethylene backing. The dosage and administration instructions advise reading the enclosed patient information before use and applying the system immediately after removing it from the pouch. The system is intended to be worn for 7 days and should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). It is important to keep this and all drugs out of the reach of children. The manufacturer is Zydus Lifesciences Ltd. and it is distributed by Zydus Pharmaceuticals (USA) Inc. The barcode area and varnished areas are also mentioned in the text. Overall, this text provides information about the estradiol transdermal system.*

This is a description for a transdermal system containing estradiol, a hormone used for hormone replacement therapy. The system provides a continuous delivery of 0.06 mg of estradiol per day and is intended to be worn for 7 days. It contains 4 transdermal systems and should be applied immediately upon removal from the pouch. The package is not child-resistant, so it should be kept out of reach of children. The system should be stored at a temperature between 20°C and 25°C (68°F and 77°F) and should not be stored above 30°C (86°F). The product is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

This text appears to be the description of a medication called "Estradiol Transdermal System, USP". It is a transdermal patch that is applied once weekly to deliver a controlled dosage of estradiol, a form of estrogen. Each patch contains 5.665 mg of estradiol, providing 0.075 mg of estradiol per day. The patch is intended to be worn for 7 days. The inactive components of the patch include acrylic adhesive, colloidal silicon dioxide, ethyl oleate, glyceryl monolaurate, isopropyl myristate, povidone, and polyethylene backing. The packaging states that it is not child-resistant and should be kept out of the reach of children. The medication should be stored between 20°C and 25°C (68°F and 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). The manufacturing and distribution of the medication are done by Zydus Lifesciences Ltd and Zydus Pharmaceuticals (USA) Inc, respectively. The text also includes various identification numbers, such as the NDC number 68382-328-04.*